Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021

SELL
$8.05 - $20.78 $1.11 Million - $2.87 Million
-137,900 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$2.58 - $3.36 $96,492 - $125,664
37,400 Added 37.21%
137,900 $361,000
Q2 2020

Oct 07, 2020

SELL
$3.01 - $4.02 $1,505 - $2,009
-500 Reduced 0.5%
100,500 $336,000
Q3 2019

Oct 30, 2019

SELL
$1.81 - $2.36 $1,810 - $2,360
-1,000 Reduced 0.98%
101,000 $218,000
Q4 2018

Jan 14, 2019

BUY
$1.21 - $1.54 $30,250 - $38,500
25,000 Added 32.47%
102,000 $143,000
Q2 2018

Jul 26, 2018

BUY
$1.64 - $2.29 $126,279 - $176,330
77,000 New
77,000 $156,000
Q1 2018

Apr 10, 2018

SELL
$1.19 - $2.17 $89,250 - $162,750
-75,000 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$0.98 - $2.27 $24,500 - $56,750
25,000 Added 50.0%
75,000 $86,000
Q3 2017

Nov 07, 2017

BUY
$1.2 - $2.84 $60,000 - $142,000
50,000
50,000 $132,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $50.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Acg Wealth Portfolio

Follow Acg Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.